🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will address the question of whether targeting CMV antigens with...
Status
Recruiting
Location
Children's Hospital Colorado
Start Date
2024-07-18
Trial ID
NCT05096481
Treatments Being Tested
The purpose of this research study is to determine if an investigational de...
Status
Completed
Location
University of Florida
Start Date
2016-08-09
Trial ID
NCT02465268
Treatments Being Tested
A single blind, randomized, comparative, multicentre clinical trial of the ...
Status
Unknown
Location
SPZOZ w Bochni Szpital Powiatowy im. bł. M. Wieckiej
Start Date
2022-12-12
Trial ID
NCT05480462
Treatments Being Tested
This study will assess the immunogenicity and reactogenicity of the candida...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT01277705
The clinical trial is a phase III, double-blind, randomised, controlled, mu...
Status
Completed
Location
H:S Rigshospitalet
Start Date
2010-01
Trial ID
NCT01033877
Treatments Being Tested
The purpose of this study is to determine the safety and feasibility of adm...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2021-09-07
Trial ID
NCT05077137
Treatments Being Tested
This is a pilot study in a small number of children and young adults with s...
Status
Recruiting
Location
Children's National Hospital
Start Date
2025-05-05
Trial ID
NCT06514898
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
Newly diagnosed glioblastoma (GBM) patients with complete or partial surgic...
Status
Terminated
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2016-12-07
Trial ID
NCT02864368
This study will evaluate the safety and immune response to GlaxoSmithKline ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00109330
Treatments Being Tested